Case Control Study
Copyright ©The Author(s) 2024.
World J Psychiatry. Mar 19, 2024; 14(3): 370-379
Published online Mar 19, 2024. doi: 10.5498/wjp.v14.i3.370
Table 1 Baseline characteristics of non-brain injured patients, n (%)

Dexmedetomidine (n = 52)
Propofol (n = 63)
P value
Age (yr), median (IQR)61.0 (55.0-64.0)61.0 (53.0-66.0)0.663
Male30 (57.7)39 (61.9)0.646
BMI (kg/m2), median (IQR)21.8 (19.6-24.3)21.1 (19.0-22.3)0.191
SAPS II, median (IQR)46.0 (38.0-54.0)46.0 (36.0-53.0)0.675
Main reason for ICU
Medical37 (71.2)44 (69.9)0.983
Surgical10 (19.2)13 (20.6)
Trauma5 (9.6)6 (9.5)
Infection at ICU admission 24 (46.2)30 (47.6)0.875
SOFA score of organ > 2
Respiratory30 (57.7)35 (55.6)0.818
Cardiovascular26 (50.0)27 (42.9)0.444
Renal8 (15.4)10 (15.9)0.943
Coagulation4 (7.7)6 (9.5)0.729
Liver1 (1.9)1 (1.6)0.891
Total SOFA score, median (IQR)7.0 (4.0-9.0)6.0 (3.0-9.0)0.954
RASS score at enrollment, median (IQR)-2 (-3 to -1)-3 (-3 to -1)0.247
Time from ICU admission to drug initiation (h), median (IQR)32.0 (20.0-35.0)31.0 (20.0-42.0)0.798